Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $417.21, denoting a -1.23% move from the…

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030

Vertex appears to be by far the better buy right now.…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $416.81, representing a +2.01% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $407.9, denoting a -1.05% move from the…

Heres Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $414.86, representing a -1.49% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading…

Vertex Pharmaceuticals Aktie: Die Schere zwischen Nasdaq Biotech und der Aktie geht weit auseinander

Paris (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von der BNP Paribas:Egmond Haidt, Analyst der BNP Paribas, nimmt die Aktie von Vertex Pharmaceuticals…

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $408.85, representing a +1.15% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $385.74, indicating a +1.01% shift from the previous trading…

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $381.87, denoting a +1.39% move from the…

Vertex Pharmaceuticals Aktie: Truist bleibt bei "buy" - doch warum sinkt das Kursziel_

Bad Marienberg (www.aktiencheck.de) - Truist bleibt bullish auf Vertex Pharmaceuticals – trotz Kurszielsenkung Ein neues Kapitel in der spannenden Geschichte von…

Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +6.60% and +2.59%, respectively, for the quarter ended June 2025. Do the…

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more

These are the stocks posting the largest moves in extended trading.…

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.…

brite(TM)-Plattform von XO Life: Digitale Therapiebegleitung für Menschen mit Mukoviszidose

XO Life GmbH: München (ots) - Vertex Pharmaceuticals, ein US-amerikanisches Pharmaunternehmen mit Fokus auf schwere Erkrankungen wie Mukoviszidose, Beta-Thalassämie und…

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $476.95, signifying a +1.45% move from its prior days close.…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $470.13, denoting a +2.54% move from the…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…

3 Top Growth Stocks to Buy in the Second Half of 2025

Key PointsAlibaba is a Chinese AI stock thats dirt cheap.Meta Platforms is making a huge bet on AI that should…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $469.55 in the latest trading session, marking a +1.15% move from the prior day.…

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Vertex Pharmaceuticals (VRTX) reached $464.2 at the closing of the latest trading day, reflecting a -1.73% change compared to its…

The Best Stocks to Invest $1,000 in Right Now

Alibaba offers an inexpensive way to invest in AI. Amazon has multiple growth opportunities, including AI, robotics, e-commerce, and…

Motley Fool Co-Founder David Gardner Reviews Stock Picks

Were approaching the 10-year anniversary of the first of Rule Breaker Investings 30 five-stock samplers, picked from 2015 to 2021.…

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz

Key PointsProKidney announced results of a Phase 2 clinical trial.The stock, which was less than $1 per share, skyrocketed on…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

The Best Stocks to Invest $1,000 In Right Now

Key PointsAlibaba offers a cheap way to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce.UnitedHealth Group is…

2 Beaten-Down Stocks With Massive Upside Potential

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues…

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

Vertex Pharmaceuticals (VRTX) reached $452.16 at the closing of the latest trading day, reflecting a +1.56% change compared to its…

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?

Investors looking for stocks that can produce dramatic gains in a short amount of time will want to turn their…

Heres Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $440.87, denoting a -1.68% move from the…

2 Growth Stocks to Buy and Hold for 10 Years

Popular themes on Wall Street today include artificial intelligence (AI), the market for weight management medicines, and the potential impact…

Vertex Pharmaceuticals Aktie: CF-Launch bleibt hinter Erwartungen - RBC senkt Kursziel auf 420 USD

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Der Analyst Brian Abrahams von RBC Capital Markets hat das Kursziel für…

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Youre unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $455.45, denoting a -1% move from the…

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

Even though broader equities have been highly volatile this year, its still a good idea to invest in stocks for…

3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…

4 Monster Stocks to Buy and Hold for the Next Decade

The U.S. equity market has been anything but calm in 2025, as several factors, including persistent trade tensions, rising macroeconomic…

2 Top Stocks to Buy Right Now

Some investors are staying away from the market right now due to the volatility stocks have experienced this year and…

3 Top Growth Stocks to Buy in the Second Half of 2025

Believe it or not, but were not far away from being halfway through the year. Time flies when youre having…

2 Monster Growth Stocks to Buy and Hold for 10 Years

The markets recent correction looks like a massive drop on a year-to-date chart. However, it will look far less daunting…

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of…

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The companys…

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

The United States, like all countries, has gone through its share of ups and downs -- from soaring economies to…

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

One of the biggest opportunities in healthcare today centers around genome editing. According to analysts at Grand View Research, the…

2 Biotech Stocks That Are Screaming Buys in May

Its very tempting to pile into the stocks with the strongest positive momentum of the moment -- theyve proven themselves…

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was,…

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Regardless of how stocks are performing right now, history tells us that the market tends to generate solid returns over…

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Uncertainty has weighed on stocks over the past several weeks, pushing the three major indexes lower -- the S&P 500…